Home LiteratureArticle Details
PMID: 7912830 Published · ppublish English Journal Article

Human immunodeficiency virus 1 Tat binds to dipeptidyl aminopeptidase IV (CD26): a possible mechanism for Tat's immunosuppressive activity.

Gutheil WG, Subramanyam M, Flentke GR, Sanford DG, Munoz E, Huber BT, Bachovchin WW

Abstract

The human immunodeficiency virus 1 (HIV-1) Tat protein suppresses antigen-induced, but not mitogen-induced, activation of human T cells when added to T-cell cultures [Viscidi, R. P., Mayur, K., Lederman, H. M. & Frankel, A. D. (1989) Science 246, 1606-1608]. This activity is potentially pertinent to the development of AIDS because lymphocytes from HIV-infected individuals exhibit a similar antigen-specific dysfunction. Here we report that Tat binds with high affinity to the T-cell activation molecule dipeptidyl aminopeptidase IV (DP IV), also known as CD26. This molecule occurs on the surface of CD4+ cells responsible for the recall antigen response and appears to play an essential role in this response. Tat binds to both the cell surface and soluble forms of DP IV at physiological salt concentrations without inhibiting the protease activity of DP IV against small chromogenic substrates used to assay activity, but Tat markedly inhibits the activity of DP IV at lower salt concentrations. The kinetics of inhibition indicate the affinity of Tat for DP IV varies from 20 pM to 11 nM, and the activity of the Tat-DP IV complex varies from 13% to 100%, as the NaCl concentration varies from 0 to 140 mM. Cytofluorometry experiments demonstrate that Tat competes with anti-Ta1, a monoclonal antibody (mAb) specific for DP IV, for binding to cell surface DP IV, thus indicating that Tat binds DP IV at or near the Ta1 epitope. Moreover, the anti-Ta1 mAb blocks the immunosuppressive activity of Tat. The high affinity of Tat for DP IV, previous evidence implicating DP IV in antigen-specific T-cell activation events, and the ability of anti-Ta1 mAb to block the immunosuppressive effect of Tat make DP IV a plausible receptor for Tat's immunosuppressive activity.

MeSH Terms
Acquired Immunodeficiency Syndrome/immunology,microbiology Antigens, Differentiation, T-Lymphocyte/metabolism Dipeptidyl Peptidase 4 Dipeptidyl-Peptidases and Tripeptidyl-Peptidases/metabolism Flow Cytometry Gene Products, tat/biosynthesis,isolation & purification,metabolism HIV-1/metabolism Humans Kinetics Mathematics Models, Theoretical Protein Binding Recombinant Proteins/biosynthesis,isolation & purification,metabolism T-Lymphocytes/immunology,microbiology tat Gene Products, Human Immunodeficiency Virus
Chemicals
Antigens, Differentiation, T-Lymphocyte Gene Products, tat Recombinant Proteins tat Gene Products, Human Immunodeficiency Virus Dipeptidyl-Peptidases and Tripeptidyl-Peptidases Dipeptidyl Peptidase 4
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Gutheil W G
Department of Biochemistry, Tufts University School of Medicine, Boston, MA 02111.
Subramanyam M
Flentke G R
Sanford D G
Munoz E
Huber B T
Bachovchin W W
References (32)
32 references, click to expand
  1. Isolation and characterization of dipeptidyl peptidase IV from human placenta.
    Eur J Biochem. 1982 Aug;126(2):359-65 PMID: 6751824
  2. Cyclophilin residues that affect noncompetitive inhibition of the protein serine phosphatase activity of calcineurin by the cyclophilin.cyclosporin A complex.
    Biochemistry. 1994 Mar 8;33(9):2380-8 PMID: 8117697
  3. A transcriptional activator protein encoded by the x-lor region of the human T-cell leukemia virus.
    Science. 1985 Jun 21;228(4706):1430-4 PMID: 2990028
  4. The trans-activator gene of the human T cell lymphotropic virus type III is required for replication.
    Cell. 1986 Mar 28;44(6):941-7 PMID: 2420471
  5. Antigen reactive memory T cells are defined by Ta1.
    J Immunol. 1986 Jul 15;137(2):414-8 PMID: 3013990
  6. Reactivity of E. coli-derived trans-activating protein of human T lymphotropic virus type III with sera from patients with acquired immune deficiency syndrome.
    J Immunol. 1986 Jul 15;137(2):669-73 PMID: 3013999
  7. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis.
    Science. 1988 Feb 5;239(4840):617-22 PMID: 3277274
  8. Bioassay for trans-activation using purified human immunodeficiency virus tat-encoded protein: trans-activation requires mRNA synthesis.
    Proc Natl Acad Sci U S A. 1989 Feb;86(3):821-4 PMID: 2536934
  9. Isolation and characterization of dipeptidyl aminopeptidase IV from human kidney cortex.
    Clin Chim Acta. 1989 Jan 13;179(1):61-71 PMID: 2563959
  10. Mechanisms of immune memory. T cell activation and CD3 phosphorylation correlates with Ta1 (CDw26) expression.
    J Immunol. 1989 Apr 15;142(8):2590-6 PMID: 2564857
  11. 1F7, a novel cell surface molecule, involved in helper function of CD4 cells.
    J Immunol. 1989 Dec 1;143(11):3430-9 PMID: 2479677
  12. Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1.
    Science. 1989 Dec 22;246(4937):1606-8 PMID: 2556795
  13. Characterization of murine monoclonal antibodies to the tat protein from human immunodeficiency virus type 1.
    J Virol. 1990 Feb;64(2):962-5 PMID: 1688630
  14. The T cell triggering molecule Tp103 is associated with dipeptidyl aminopeptidase IV activity.
    J Immunol. 1990 Apr 15;144(8):2908-14 PMID: 1969875
  15. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients.
    Nature. 1990 May 3;345(6270):84-6 PMID: 2184372
  16. Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals.
    Proc Natl Acad Sci U S A. 1990 Aug;87(16):6058-62 PMID: 2385584
  17. Inhibition of dipeptidyl aminopeptidase IV (DP-IV) by Xaa-boroPro dipeptides and use of these inhibitors to examine the role of DP-IV in T-cell function.
    Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1556-9 PMID: 1671716
  18. Transcellular transactivation by the human immunodeficiency virus type 1 tat protein.
    J Virol. 1991 Aug;65(8):4547-9 PMID: 2072464
  19. Refolded HIV-1 tat protein protects both bulge and loop nucleotides in TAR RNA from ribonucleolytic cleavage.
    Biochemistry. 1991 Aug 13;30(32):8060-6 PMID: 1868081
  20. Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes.
    J Immunol. 1991 Oct 15;147(8):2514-7 PMID: 1680916
  21. cDNA cloning for mouse thymocyte-activating molecule. A multifunctional ecto-dipeptidyl peptidase IV (CD26) included in a subgroup of serine proteases.
    J Biol Chem. 1992 Feb 5;267(4):2200-8 PMID: 1370813
  22. Preparative purification of dipeptidyl peptidase IV.
    Prep Biochem. 1991;21(2-3):141-50 PMID: 1686804
  23. Expression of CD26 (dipeptidyl peptidase IV) on memory and naive T lymphocytes.
    Scand J Immunol. 1992 May;35(5):551-9 PMID: 1374571
  24. Selective decrease of CD26 expression in T cells from HIV-1-infected individuals.
    J Immunol. 1992 Nov 1;149(9):3073-7 PMID: 1357035
  25. An unusual antibody that blocks tissue factor/factor VIIa function by inhibiting cleavage only of macromolecular substrates.
    Blood. 1992 Dec 15;80(12):3127-34 PMID: 1467519
  26. Mechanism of HIV-1 Tat induced inhibition of antigen-specific T cell responsiveness.
    J Immunol. 1993 Mar 15;150(6):2544-53 PMID: 8095514
  27. A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase.
    J Exp Med. 1993 Apr 1;177(4):1135-43 PMID: 8096237
  28. Decreased expression of the memory marker CD26 on both CD4+ and CD8+ T lymphocytes of HIV-infected subjects.
    J Acquir Immune Defic Syndr. 1993 Jul;6(7):749-57 PMID: 8099610
  29. Direct association of adenosine deaminase with a T cell activation antigen, CD26.
    Science. 1993 Jul 23;261(5120):466-9 PMID: 8101391
  30. Separation of L-Pro-DL-boroPro into its component diastereomers and kinetic analysis of their inhibition of dipeptidyl peptidase IV. A new method for the analysis of slow, tight-binding inhibition.
    Biochemistry. 1993 Aug 31;32(34):8723-31 PMID: 8103356
  31. T cell activation antigen, CD26, as a cofactor for entry of HIV in CD4+ cells.
    Science. 1993 Dec 24;262(5142):2045-50 PMID: 7903479
  32. Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition.
    N Engl J Med. 1985 Jul 11;313(2):79-84 PMID: 2582258
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1994-07-05
Pages
6594-8
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC44249
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com